These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37107208)

  • 1. Mediterranean Diet Improves Plasma Biomarkers Related to Oxidative Stress and Inflammatory Process in Patients with Non-Alcoholic Fatty Liver Disease.
    Quetglas-Llabrés MM; Monserrat-Mesquida M; Bouzas C; Llompart I; Mateos D; Casares M; Ugarriza L; Martínez JA; Tur JA; Sureda A
    Antioxidants (Basel); 2023 Mar; 12(4):. PubMed ID: 37107208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Adherence to the Mediterranean Diet after Lifestyle Intervention Improves Oxidative and Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease.
    Monserrat-Mesquida M; Quetglas-Llabrés M; Bouzas C; Montemayor S; Mascaró CM; Casares M; Llompart I; Ugarriza L; Martínez JA; Tur JA; Sureda A
    Antioxidants (Basel); 2022 Jul; 11(8):. PubMed ID: 35892642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Greater Improvement of Intrahepatic Fat Contents after 6 Months of Lifestyle Intervention Is Related to a Better Oxidative Stress and Inflammatory Status in Non-Alcoholic Fatty Liver Disease.
    Monserrat-Mesquida M; Quetglas-Llabrés M; Bouzas C; Montemayor S; Mascaró CM; Casares M; Llompart I; Gámez JM; Tejada S; Martínez JA; Tur JA; Sureda A
    Antioxidants (Basel); 2022 Jun; 11(7):. PubMed ID: 35883758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to Mediterranean Diet and NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study.
    Montemayor S; Mascaró CM; Ugarriza L; Casares M; Llompart I; Abete I; Zulet MÁ; Martínez JA; Tur JA; Bouzas C
    Nutrients; 2022 Aug; 14(15):. PubMed ID: 35956364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Adherence to the Mediterranean Diet on Antioxidant Status and Metabolic Parameters in NAFLD Patients: A 24-Month Lifestyle Intervention Study.
    Quetglas-Llabrés MM; Monserrat-Mesquida M; Bouzas C; García S; Argelich E; Casares M; Ugarriza L; Llompart I; Tur JA; Sureda A
    Antioxidants (Basel); 2024 Apr; 13(4):. PubMed ID: 38671927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease.
    Monserrat-Mesquida M; Quetglas-Llabrés M; Abbate M; Montemayor S; Mascaró CM; Casares M; Tejada S; Abete I; Zulet MA; Tur JA; Martínez JA; Sureda A
    Antioxidants (Basel); 2020 Aug; 9(8):. PubMed ID: 32824349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Dietary and Lifestyle Interventions on the Amelioration of NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study.
    Montemayor S; Bouzas C; Mascaró CM; Casares M; Llompart I; Abete I; Angullo-Martinez E; Zulet MÁ; Martínez JA; Tur JA
    Nutrients; 2022 May; 14(11):. PubMed ID: 35684022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease.
    Biolato M; Manca F; Marrone G; Cefalo C; Racco S; Miggiano GA; Valenza V; Gasbarrini A; Miele L; Grieco A
    World J Gastroenterol; 2019 Jan; 25(4):509-520. PubMed ID: 30700946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Fatty Acid Composition, Oxidative and Inflammatory Status, and Adherence to the Mediterranean Diet of Patients with Non-Alcoholic Fatty Liver Disease.
    Monserrat-Mesquida M; Quetglas-Llabrés MM; Bouzas C; Pastor O; Ugarriza L; Llompart I; Cevallos-Ibarra K; Sureda A; Tur JA
    Antioxidants (Basel); 2023 Aug; 12(8):. PubMed ID: 37627549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Permeability Might be Improved by Dietary Fiber in Individuals with Nonalcoholic Fatty Liver Disease (NAFLD) Undergoing Weight Reduction.
    Krawczyk M; Maciejewska D; Ryterska K; Czerwińka-Rogowska M; Jamioł-Milc D; Skonieczna-Żydecka K; Milkiewicz P; Raszeja-Wyszomirska J; Stachowska E
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of Mediterranean diet on hepatic steatosis, oxidative stress, and inflammation in adolescents with non-alcoholic fatty liver disease: A randomized controlled trial.
    Yurtdaş G; Akbulut G; Baran M; Yılmaz C
    Pediatr Obes; 2022 Apr; 17(4):e12872. PubMed ID: 34881510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern.
    Nier A; Brandt A; Conzelmann IB; Özel Y; Bergheim I
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30235828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease.
    Gelli C; Tarocchi M; Abenavoli L; Di Renzo L; Galli A; De Lorenzo A
    World J Gastroenterol; 2017 May; 23(17):3150-3162. PubMed ID: 28533672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a Six-Month Lifestyle Intervention on the Physical Activity and Fitness Status of Adults with NAFLD and Metabolic Syndrome.
    Mascaró CM; Bouzas C; Montemayor S; Casares M; Llompart I; Ugarriza L; Borràs PA; Martínez JA; Tur JA
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study.
    Abenavoli L; Greco M; Milic N; Accattato F; Foti D; Gulletta E; Luzza F
    Nutrients; 2017 Aug; 9(8):. PubMed ID: 28805669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Physical Activity and Non-Alcoholic Fatty Liver Disease in Adults with Metabolic Syndrome: The FLIPAN Study.
    Mascaró CM; Bouzas C; Montemayor S; Casares M; Gómez C; Ugarriza L; Borràs PA; Martínez JA; Tur JA
    Nutrients; 2022 Mar; 14(5):. PubMed ID: 35268038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study.
    Perez-Diaz-Del-Campo N; Marin-Alejandre BA; Cantero I; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Riezu-Boj JI; Milagro FI; Tur JA; Martinez JA; Abete I; Zulet MA
    Eur J Nutr; 2021 Sep; 60(6):3043-3057. PubMed ID: 33474638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (
    Molina-Molina E; Shanmugam H; Di Ciaula A; Grattagliano I; Di Palo DM; Palmieri VO; Portincasa P
    JHEP Rep; 2021 Feb; 3(1):100203. PubMed ID: 33490935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Path of Mediterranean Diet, Non-Alcoholic Fatty Liver Disease (NAFLD) and Inflammation towards 10-Year Cardiovascular Disease (CVD) Risk: The ATTICA Study 10-Year Follow-Up (2002-2012).
    George ES; Georgousopoulou EN; Mellor DD; Chrysohoou C; Pitsavos C; Panagiotakos DB
    Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.